(Press-News.org) Australian researchers have for the first time pinpointed specific genetic changes that increase the risk of severe, sight-threatening forms of age-related macular degeneration (AMD).
A new study, published today in Nature Communications, reveals the specific genetic factors linked to the presence of reticular pseudodrusen - deposits which drive vision loss and are found on the retina of up to 60 per cent of people with advanced AMD.
The research, led by the Centre for Eye Research Australia, WEHI and the University of Melbourne, offers a promising new target for treatments aimed at the most severe forms of AMD, including geographic atrophy.
AMD is a leading cause of irreversible blindness in people over 50 worldwide, resulting from the death of light-sensing cells in the macula, the part of the retina needed for central vision.
Globally, more than 196 million people have AMD. In its early stages, it is difficult to predict who is most at risk of vision loss and when treatment should begin. Current therapies can only slow disease progression once significant damage has occurred.
The Australian team led a large international study which, for the first time, pinpointed a key difference in genetic changes in the group with reticular pseudodrusen – finding a strong link with genetic variations on Chromosome 10 but no link to other well-known AMD genes changes on Chromosome 1.
Eye scans of people with this genetic variation also revealed a thinner retina, a finding that warrants further investigation.
Study co-lead Professor Robyn Guymer AM, from the Centre for Eye Research Australia, said the results highlight that AMD is not a single disease but a group of related conditions potentially requiring tailored treatment approaches.
“Reticular pseudodrusen deposits, visible in eye scans, have been linked to worse visual function and poorer treatment outcomes,’’ she said.
“Our research has now identified which of the genetic changes appear to be driving this more serious form of AMD. This discovery provides a crucial lead for developing new drugs that target these changes—potentially preventing vision loss before it begins.”
Co-lead Professor Melanie Bahlo AM from WEHI said this was the first genome-wide analysis of the genetic drivers behind reticular pseudodrusen.
“In 2005, researchers first linked changes on Chromosome 1 including the complement factor H (CFH) gene, part of the immune system, to AMD,’’ she said. “Recently, new treatments targeting these changes have shown modest success in slowing down the disease.
“Our study is the first to suggest that reticular pseudodrusen deposits are driven by pathways associated with Chromosome 10 but not by the well-known AMD-related genes on Chromosome 1.
“This is a significant finding. It demonstrates the need to explore how genetic changes on Chromosome 10 affect retinal structure and to develop therapies that go beyond complement factor to targeting to prevent sight-threatening deposits on the retina.”
The research was funded by a National Health and Medical Research Council Synergy Grant.
Read the study: Farashi S, et al. HTRA1/lncRNA HTRA1-AS1 dominates in Age-Related Macular Degeneration Reticular Pseudodrusen Genetic Risk with no Complement involvement. Nature Communications. 2025, doi: 10.1038/s41467-025-65903-9
END
Australian scientists reveal new genetic risk for severe macular degeneration
2025-12-08
ELSE PRESS RELEASES FROM THIS DATE:
GLP-1 receptor agonists likely have little or no effect on obesity-related cancer risk
2025-12-08
Embargoed for release until 5:00 p.m. ET on Monday 8 December 2025
Follow @Annalsofim on X, Facebook, Instagram, Bluesky, and Linkedin
Below please find summaries of new articles that will be published in the next issue of Annals of Internal Medicine. The summaries are not intended to substitute for the full articles as a source of information. This information is under strict embargo and by taking it into possession, media representatives are committing to the terms of the embargo not only on their own behalf, but also on behalf of the organization ...
Precision immunotherapy to improve sepsis outcomes
2025-12-08
About The Study: Among patients with sepsis, precision immunotherapy targeting macrophage activation–like syndrome and sepsis-induced immunoparalysis improved organ dysfunction by day 9 compared with placebo.
Corresponding Author: To contact the corresponding author, Evangelos J. Giamarellos-Bourboulis, MD, PhD, email egiamarel@med.uoa.gr.
To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/
(doi:10.1001/jama.2025.24175)
Editor’s Note: Please see the article for additional information, including other ...
Insilico Medicine unveils winter edition of Pharma.AI, accelerating the path to pharmaceutical superintelligence
2025-12-08
The topics of human-level artificial general intelligence (AGI) and artificial superintelligence (ASI) have captivated researchers for decades. Interest has surged with the rapid progress and deployment of large language models (LLMs), which now handle tasks such as coding, scientific explanation, creative writing, and multimodal reasoning. “Solve AI and it will solve everything” remains a popular, if contested, credo—driving large-scale investment, shaping public narratives, and motivating optimism about transformative advances.
Applying this vision to the healthcare and pharmaceutical industries, ...
Study finds most people trust doctors more than AI but see its potential for cancer diagnosis
2025-12-08
FOR IMMEDIATE RELEASE
EMBARGOED UNTIL DECEMBER 8, 2025
Study Finds Most People Trust Doctors More than AI But See Its Potential for Cancer Diagnosis
Nationally representative surveys measure public attitudes toward AI in healthcare
Washington, D.C., December 8, 2025– New research on public attitudes toward AI indicates that most people are reluctant to let ChatGPT and other AI tools diagnose their health condition, but see promise in technologies that use AI to help diagnose cancer. These and other results of two nationally representative surveys will be presented at the ...
School reopening during COVID-19 pandemic associated with improvement in children’s mental health
2025-12-08
Embargoed for release: Monday, December 8, 2025, 4:00 PM ET
Key points:
Children whose schools reopened during the COVID-19 pandemic had significantly decreased mental health diagnoses relative to children whose schools remained closed, according to a new study of schools across California. This included fewer diagnoses of depression, anxiety, and ADHD. Girls’ mental health benefited the most.
Mental health care spending decreased by up to 11% by the ninth month after a school’s reopening.
The study is among the largest and most data-rich examinations of how school closures impacted ...
Research alert: Old molecules show promise for fighting resistant strains of COVID-19 virus
2025-12-08
SARS‑CoV‑2, the virus that causes COVID-19, continues to mutate, with some newer strains becoming less responsive to current antiviral treatments like Paxlovid. Now, University of California San Diego scientists and an international team of researchers have identified several promising molecules that could lead to new medications capable of combating these resistant variants.
Instead of looking for antiviral candidates from scratch, the research team screened 141 previously synthesized compounds that had originally been designed between 1997 and 2012 to inhibit a key enzyme called cruzain. ...
Journal of Nuclear Medicine Technology supplement highlights advances in theranostics and opportunities for growth
2025-12-08
Reston, VA (December 8, 2025) As nuclear medicine theranostics expands rapidly across clinical practice worldwide, a new supplement to the Journal of Nuclear Medicine Technology (JNMT) explores how nuclear medicine technologists are embracing their growing role within the field. Titled, Building the Future of Theranostics: Advancing Practice, Education, and Innovation Worldwide, the supplement brings together voices from across the globe, offering perspectives that span clinical lessons, educational frameworks, operational strategies, advocacy, equity, and biology.
From the early use of ...
New paper rocks earthquake science with a clever computational trick
2025-12-08
Hoboken, N.J., December 8, 2025 — On Saturday December 6, 2025 Alaska was rocked by a 7.0 magnitude quake. Though not always so forceful, earthquakes happen every day. On average, about 55 of them strike daily, according to the United States Geological Survey (USGS), totaling some 20,000 annually worldwide. About once a year, one reaches 8.0 points or greater and 15 others hit within the magnitude 7 range on the Richter scale, which measures earthquakes by the energy they release. For example, in just 2025 an 8.8 earthquake offshore from the Kamchatka Peninsula in Russia, ...
ASH 2025: Milder chemo works for rare, aggressive lymphoma
2025-12-08
MIAMI, FLORIDA (EMBARGOED UNTIL DEC. 8, 2025, AT 2:45 P.M. EST) – Most patients with a rare and aggressive form of large B-cell lymphoma can safely receive a less toxic treatment than the intensive chemotherapy often used, according to new research from Sylvester Comprehensive Cancer Center, part of the University of Miami Miller School of Medicine.
Lead researcher Juan Alderuccio, M.D., a hematologist and lymphoma specialist at Sylvester, will present this research Dec. 8 at the American Society of Hematology ...
Olfaction written in bones: New insights into the evolution of the sense of smell in mammals
2025-12-08
The sense of smell is vital for animals, as it helps them find food, protect themselves from predators and interact socially. An international research team led by Dr Quentin Martinez and Dr Eli Amson from State Museum of Natural History Stuttgart has now discovered that certain areas of the brain skull allow conclusions to be drawn about the sense of smell in mammals. Particularly significant is the volume of the endocast of the olfactory bulb, a bony structure in the skull that is often well preserved even in very old fossils. This volume is closely related to the number of intact odour receptor genes – an important ...